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Abstract
Fusarium spp. have recently emerged as signiﬁcant human pathogens. Identiﬁcation of these species is important, both for epidemiologi-
cal purposes and for patient management, but conventional identiﬁcation based on morphological traits is hindered by major phenotypic
polymorphism. In this study, 62 strains, or isolates, belonging to nine Fusarium species were subjected to both molecular identiﬁcation
TEF1 gene sequencing and matrix-assisted laser desorption ionization–time-of-ﬂight (MALDI–TOF) analysis. Following stringent standard-
ization, the proteomic-based method appeared to be both reproducible and robust. Mass spectral analysis by comparison with a data-
base, built in this study, of the most frequently isolated species, including Fusarium solani, Fusarium oxysporum, Fusarium verticilloides,
Fusarium proliferatum and Fusarium dimerum, correctly identiﬁed 57 strains. As expected, the four species (i.e. Fusarium chlamydosporum,
Fusarium equiseti, Fusarium polyphialidicum, Fusarium sacchari) not represented in the database were not identiﬁed. Results from mass
spectrometry and molecular identiﬁcation agreed in ﬁve of the six cases in which results from morphological and molecular identiﬁca-
tion were not in agreement. MALDI–TOF yielded results within 1 h, making it a valuable tool for identifying clinical Fusarium isolates at
the species level. Uncommon species must now be added to the database. MALDI–TOF may also prove useful for identifying other
clinically important moulds.
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Introduction
The fungal kingdom is estimated to comprise some 1.5 million
species, of which less than one-third have so far been identi-
ﬁed. Since the 1980s, the incidence of fungal infections in
humans has increased [1,2], as has the diversity of human fun-
gal pathogens [3,4]. Among the most signiﬁcant emerging
pathogens are yeasts such as Candida glabrata and ﬁlamentous
fungi (e.g. Scedosporium spp., Fusarium spp. and Mucorales).
Approximately 500 different fungal species have now been
implicated in at least one case of human infection [5]. These
emerging fungal pathogens are difﬁcult to identify, owing to a
lack of speciﬁc tools, and tend to be less susceptible to avail-
able antifungal drugs. These two factors may contribute to high
case fatality rates.
Identiﬁcation of fungal pathogens is hindered by several fac-
tors. In particular, their taxonomy is sometimes complex and
irrational. Indeed, the concept of biological species does not
apply to many fungal pathogens (e.g. Candida albicans, C. glab-
rata and Aspergillus fumigatus) as no sexual stage has yet been
described [5]. Approximately 85–95% of yeast isolates can be
identiﬁed on the basis of biochemical and/or morphological
traits. By contrast, the macroscopic and microscopic aspects
of ﬁlamentous fungi are highly subjective, often leading to
inconclusive or erroneous identiﬁcation. These difﬁculties
have led to the development of molecular approaches to fun-
gal identiﬁcation. Indeed, the phylogenetic species concept is
probably the most reliable, but it requires in-depth analysis
before it can be applied to a given group of organisms [6].
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The genus Fusarium provides an excellent illustration of
these difﬁculties. These ﬁlamentous fungi are widespread
[7], notably causing cereal diseases with important eco-
nomic repercussions. Fusarium solani, Fusarium verticillioides
(syn. Fusarium moniliforme) and Fusarium oxysporum are the
most frequently isolated species in the clinical setting, but
at least 13 other species have been implicated in human
infections. Some Fusarium species can cause both superﬁcial
mycoses (e.g. onychomycosis and keratitis) and life-
threatening invasive infections, mainly in immunocompro-
mised patients [8–10]. The taxonomy of the genus
Fusarium is one of the most complex, notably because
various classiﬁcations are used, including subgenus and sub-
species categories such as sections and formae speciales,
and because of the duality between teleomorph (sexual
stage) and anamorph (asexual stage) taxonomies. Addition-
ally, phenotypic variability in this genus is well known [11],
placing Fusarium spp. among the species most difﬁcult
to identify by conventional methods (macroscopic and
microscopic examination). Molecular approaches have made
the situation even more complex as morphological species
such as F. solani have been demonstrated to encompass
not less than 45 distinct phylogenetic species, leading to
the denomination of the F. solani species complex [12].
Direct sequencing methods targeting different DNA frag-
ments have thus been developed for Fusarium species
identiﬁcation [13–16]. Among these targets, the translation
elongation factor 1-a (TEF1) gene seems to be the
most valuable, but has not been widely used to identify
clinical isolates [15,17]. However, correct species identiﬁ-
cation is important, not only for epidemiological purposes,
but also for therapeutic management because, for example,
isolates of the F. solani species complex are signiﬁ-
cantly less susceptible than those of other species to new
azole derivatives such as voriconazole and posaconazole
[18,19].
Matrix-assisted laser desorption ionization–time-of-ﬂight
(MALDI–TOF) analysis is a rapid and sensitive technique that
has recently gained popularity as a tool for characterizing
microorganisms [20]. Several studies have applied this
approach to fungi [21–24], but no standardized protocol and
no validated database have been proposed.
Here, we report the use of mass spectrometry to iden-
tify clinical Fusarium isolates at the species level. The objec-
tives were: (i) to evaluate the reliability of the method
compared with molecular identiﬁcation; (ii) to determine
the inﬂuence of factors such as growth temperature and
culture medium on the mass spectrometry proﬁle, and (iii)
to validate a database for routine identiﬁcation of clinical
Fusarium isolates.
Materials and Methods
Strains
A set of 62 strains, or isolates, was available for testing
(Table 1). Most strains were collected from superﬁcial (skin,
ungueal scrapings, cornea) or deep (blood, bronchoalveolar
lavage ﬂuid) sites of infection. Two environmental isolates
collected within the Hoˆpital St Antoine, Paris were also
included. Twenty-six strains were deposited in the Institute
of Hygiene and Epidemiology (IHEM) collection in Brussels
(http://bccm.belspo.be/). They were identiﬁed according to
their macroscopic and microscopic characteristics (conidio-
genesis, aspect of conidia), using a reference guide [25]. They
belonged to eight different species, namely, F. oxysporum,
F. solani, F. verticillioides, Fusarium proliferatum, Fusarium dime-
rum, Fusarium equiseti, Fusarium chlamydosporum and Fusarium
polyphialidicum, corresponding to those predominantly
involved in human infections. All strains were stored at
) 80 C in 10% glycerol until use.
Molecular identiﬁcation
Molecular identiﬁcation was based on direct sequencing of a
fragment of the TEF1 gene, as described by Geiser et al. [15].
Brieﬂy, strains were sub-cultured on Sabouraud dextrose agar
plates for 2 days at 27 C. DNA was extracted by thermal
lysis, followed by chelation of non-DNA cell components,
which were discarded by centrifugation [13]. The PCR mix
consisted of a 50-lL ﬁnal volume containing 0.25 mM deoxy-
nucleotide triphosphate, 0.25 lM each primer EF1 (5¢-AT
GGGTAAGGA(A/G)GACAAGAC-3¢) and EF2 (5¢-GGA(G/
A)GTACCAGT(G/C)ATCATGTT-3¢), 1.5 units of Taq poly-
merase (New England Biolabs, Inc., Ipswich, MA, USA) and
10 lL DNA. Cycling conditions were as follows: 94 C for
5 min, followed by 30 cycles of 94 C for 30 s, 52 C for 30 s,
72 C for 90 s, and a ﬁnal extension step at 72 C for 10 min.
Sequences were determined on both strands using the Big Dye
Terminator protocol (Applied Biosystems, Inc., Courtaboeuf,
France) with the primers used for ampliﬁcation. Following
manual correction, sequences were compared using blast
software against the Fusarium-Seq Version 1.0 database (http://
Fusarium.cbio.psu.edu) and the GenBank database (http://www.
ncbi.nlm.nih.gov/BLAST/) limited to the genus Fusarium.
Mass spectrometry
Protein extraction and mass spectrum acquisition. Culture of malt
agar plates (AES Laboratoire Groupe, Combourg, France) for
72 h at 27 C was designated as the reference condition. The
surfaces of the colonies were scraped using a sterile scalpel
and suspended in 50 lL 80% triﬂuoroacetic acid (TFA) for
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30 min. Then 150 lL of distilled water was added, followed by
200 lL of acetonitrile. The mixture was centrifuged at
12 000 g for 2 min, and the supernatant was either vacuum-
dried and stored at ) 80 C, or directly spotted (0.5 lL drop-
let) in duplicate onto a MALDI AnchorChip sample slide
(Bruker-Daltonik GmbH, Bremen, Germany) and then air-
dried. The a-cyano-4-hydroxy-cinnamic acid (CHCA) matrix
(Bruker-Daltonik GmbH), prepared at a concentration of
TABLE 1. Fusarium strains used in this work with their respective identiﬁcation using different typing methods
Strain Site of isolation
Morphological
identiﬁcation
Molecular identiﬁcationa Mass spectrometry identiﬁcationb
blast n ﬁrst hit % identity
Most frequent
Biotyper ﬁrst hit
% of Biotyper
ﬁrst hit
IHEM10150 Reed stem (Arundo donax) F. chlamydosporum – – F. solani 50
26 Hospital environment F. dimerum F. dimerum 99 F. dimerum 75
IHEM10066c Aortic valve F. dimerum F. dimerum 100 F. dimerum 100
IHEM19306 Soil F. equiseti F. equiseti 96 F. solani 50
4 Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
10 Nail F. oxysporum F. oxysporum 100 F. oxysporum 75
11 Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
14 Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
20 Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
21 Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
30 Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
32c Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
38 Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
44c Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
52 Nail F. oxysporum F. oxysporum 100 F. oxysporum 75
53c Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
102 Nail F. oxysporum F. oxysporum 100 F. oxysporum 100
IHEM19748 Soil F. polyphialidicum – – F. solani 50
8c Nail F. proliferatum F. proliferatum 99 F. proliferatum 100
47c Cutaneous biopsy F. proliferatum F. proliferatum 99 F. proliferatum 100
49 Bronchial aspiration F. proliferatum F. proliferatum 99 F. proliferatum 100
101 Nail F. proliferatum F. proliferatum 100 F. proliferatum 100
IHEM3824 Not speciﬁed F. verticillioides F. proliferatum 99 F. proliferatum 100
IHEM5689 Cutaneous biopsy F. verticillioides F. proliferatum 99 F. proliferatum 100
IHEM6824 Carpet dust F. proliferatum F. proliferatum 100 F. proliferatum 100
IHEM7412 Cornea F. verticillioides F. pseudonygamai 99 F. proliferatum 100
IHEM10152c Banana bud rot (Musa sp.) F. proliferatum F. proliferatum 100 F. proliferatum 100
IHEM20165 Cutaneous biopsy F. proliferatum – – F. proliferatum 100
IHEM20272 Sinus F. proliferatum F. proliferatum 100 F. proliferatum 100
2 Nail F. solani F. solani 100 F. solani 100
3 Nail F. solani F. solani 100 F. solani 75
6 Nail F. solani F. solani 100 F. solani 100
7 Nail F. solani F. solani 100 F. solani 75
16 Toeweb F. solani F. solani 100 F. solani 100
17 Nail F. solani F. solani 100 F. solani 100
22 Nail F. solani F. solani 100 F. solani 100
23c Nail F. solani F. solani 100 F. solani 100
24 Nail F. solani F. solani 100 F. solani 75
31 Nail F. solani F. solani 100 F. solani 100
33 Nail F. solani F. solani 100 F. solani 100
35 Nail F. solani F. solani 100 F. solani 100
36 Nail F. solani F. solani 100 F. solani 100
43 Nail F. solani F. solani 100 F. solani 100
46 Cutaneous biopsy F. solani F. solani 100 F. solani 100
50c Toe web F. solani F. solani 100 F. solani 100
54 Nail F. solani F. solani 99 F. solani 100
IHEM15469c Blood F. solani F. solani 99 F. solani 100
IHEM4194 Blood F. proliferatum F. verticillioides 100 F. verticillioides 100
IHEM4195 Blood F. verticillioides F. verticillioides 100 F. verticillioides 100
IHEM4197c Peritoneal ﬂuid F. verticillioides F. verticillioides 100 F. verticillioides 100
IHEM9526 Aortic valve F. verticillioides F. verticillioides 100 F. verticillioides 100
IHEM9529 Drain F. verticillioides F. verticillioides 100 F. verticillioides 100
IHEM9533 Pericardial ﬂuid F. verticillioides F. verticillioides 100 F. verticillioides 100
IHEM9576 Vitreous humour F. verticillioides F. verticillioides 100 F. verticillioides 100
IHEM9577 Eye F. proliferatum F. verticillioides 100 F. verticillioides 100
IHEM9578 Hospital environment F. proliferatum F. verticillioides 100 F. verticillioides 100
IHEM9835 Oral secretion F. verticillioides F. verticillioides 100 F. verticillioides 100
IHEM10153c Maize stem (Zea mays) F. verticillioides F. verticillioides 100 F. verticillioides 100
IHEM18495c Hospital environment (sink) F. verticillioides F. verticillioides 100 F. verticillioides 100
IHEM19667 Blood F. verticillioides F. verticillioides 99 F. verticillioides 100
IHEM20180 Sinus biopsy F. verticillioides F. verticillioides 100 F. verticillioides 100
103 Blood Fusarium sp. F. sacchari 99 F. proliferatum 50
All clinical strains were isolated from human; strains with identiﬁcation discrepancies are underlined.
aMolecular identiﬁcation based on TEF1 gene sequence comparison.
bMass spectrometry identiﬁcation based on an algorithm (see Fig. 1).
cSelected strains used to construct the database.
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50 mg/mL in 50% acetonitrile, 50% water with 0.1% TFA, was
sonicated for 5 min before being spotted (0.5 lL) over the
dried sample. A DH5 alpha Escherichia coli protein extract
(Bruker-Daltonik GmbH) was deposited on the calibration
spot of the AnchorChip for external calibration.
MALDI analysis was performed on a Bruker Autoﬂex I
MALDI–TOF mass spectrometer with a nitrogen laser
(337 nm) operating in linear mode with delayed extraction
(260 ns) at 20 kV accelerating voltage. Each spectrum was
automatically collected in the positive ion mode as an aver-
age of 500 laser shots (50 laser shots at 10 different spot
positions). Laser energy was set just above the threshold for
ion production. Based on previous work [23], a mass range
of 3000–20 000 m/z (ratio mass/charge) was selected to col-
lect the signals with the AutoXecute tool of Flexcontrol
acquisition software (Version 2.4; Bruker-Daltonik GmbH).
Only peaks with a signal/noise ratio > 3 were considered.
Spectra were eligible for further analysis when the peaks had
a resolution better than 600.
Species identiﬁcation process. Data were processed with Bio-
typer 1.0 software (Bruker-Daltonik GmbH) in order to
obtain a normalized spectrum with respect to the highest
peak. All peaks in the m/z mass range 3000–20 000, with a
threshold of 0.01 (minimum 1% of the highest peak inten-
sity), were considered. The spectrum proﬁles obtained were
then transformed into tables, including mass peaks and their
respective intensities, which were used for further compari-
son. Based on preliminary results, the number of relevant
peaks in mass spectra was limited to 50 (data not shown). A
database was built using main spectrum proﬁles (MSPs) of
three strains of F. oxysporum, F. solani, F. verticillioides and
F. proliferatum and one strain of F. dimerum (Table 1). The
MSP consists of a general proﬁle created from the peaks
retrieved from at least 50% of 10 spectra collected under
the same conditions (ﬁve extracts collected under the same
conditions tested in duplicate). The comparison of new spec-
tra against the database releases a ﬁrst hit associated with
two scores: real score (RS) and real p-number (RPN). Real
score is deﬁned as the number of peaks of the unknown spe-
cies that can be attributed to an MSP, and RPN refers to the
proportion of non-attributed peaks of the test strain in rela-
tion to the proportion of attributed peaks of the associated
MSP. The closer the values of these scores are to 1, the
more signiﬁcant is the hit. Signiﬁcant thresholds recom-
mended by the manufacturer are 0.3 and 0.2, respectively.
Evaluation of the method. The robustness of the method to
identify species was evaluated by testing a number of possi-
ble inﬂuencing factors. This was performed in ﬁve strains
representative of each of the species most frequently iso-
lated from human infections, namely, F. oxysporum (no. 32),
F. proliferatum (no. 8), F. verticillioides (IHEM4197), F. dimerum
(IHEM10066) and F. solani (IHEM15469). Each generated
spectrum was compared with the MSP database, and the
Biotyper ﬁrst hit, RS and RPN were recorded. Repeatability
was evaluated by testing colonies sampled from three dif-
ferent areas of the same culture plate. Results of duplicate
assays of each extract were also analysed. Reproducibility
was evaluated by comparing spectra obtained from two
independent experiments using our reference protocol
(malt agar, incubation at 27 C for 72 h). To determine the
effects of the culture medium, strains were plated on our
reference medium of malt agar and two other media, Sab-
ouraud chloramphenicol (200 mg/L) gentamicin (40 mg/L)
agar (SCG) (Bio-Rad, Marnes la Coquette, France), and
potato dextrose agar (PDA) (Difco Laboratories, Paris,
France), with incubation at 27 C for 72 h. The effect of
temperature was evaluated by comparing spectra obtained
from colonies cultured on malt agar for 72 h at 27 C and
37 C with the MSPs of the database. Three colonies per
plate were tested in duplicate, thus providing six compari-
son scores which were used to establish a mean. Finally,
the stability of the proﬁles over generations was tested
using a series of extracts obtained from subcultures per-
formed every 72 h over 6 weeks (11–13 extracts). For
these experiments, spectra were generated from three col-
onies sampled from each plate (six spectra per strain).
To validate our database as a tool for routine species
identiﬁcation, a panel of 49 morphologically and molecularly
identiﬁed strains was blindly tested using the MALDI–TOF
procedure. For each strain, four spectra, obtained from
two colonies tested in duplicate, were collected using our
protocol, and compared with the MSPs of the database
using Biotyper software. The species ﬁrst hit, RS and RPN
were collected for each spectrum. However, because the
spectra obtained with F. solani strains showed a very limited
number of peaks, we reduced the RPN score threshold for
validated identiﬁcation to 0.1. An algorithm for Fusarium
species identiﬁcation was thus developed, taking into
account the results obtained for the four proﬁles associated
with each strain and their respective RS and RPN scores
(Fig. 1).
Results
A panel of 62 Fusarium strains was tentatively identiﬁed at
the species level with both DNA sequencing and mass
spectrometry.
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Molecular identiﬁcation
A partial sequence of the TEF1 gene was obtained for 59
strains and compared with the GenBank and Fusarium-Seq
databases. Of these strains, 47 had 100% identity with at
least one sequence in the databases. Eleven strains, of which
six had the morphological aspect of F. proliferatum, exhibited
99% sequence identity with strains of this species and one
F. equiseti strain (IHEM19306) achieved sequence identity of
only 96%. Discrepancies between morphological and molecu-
lar identiﬁcation were found for six strains; three of these
with the morphological aspect of F. proliferatum were identi-
ﬁed as F. verticillioides using sequencing, and three strains with
the morphological aspect of F. verticillioides were identiﬁed as
F. proliferatum (two strains) and Fusarium pseudonygamai (one
strain) using sequencing (Table 1). One strain that could not
be identiﬁed at species level by morphological methods was
identiﬁed as Fusarium sacchari based on the nucleotide
sequence of the TEF1 gene.
Mass spectrometry identiﬁcation
The majority of ions detected were in the range of 3000–
10 000 Da. Figure 2 shows examples of spectra collected
before the pre-processing step. For further comparisons, a
database composed of MSPs from strains representative of
the ﬁve species most frequently isolated in human infections
(F. solani, F. verticillioides, F. oxysporum, F. proliferatum and
F. dimerum) was constructed. No single peak could be identi-
ﬁed as a marker of a given species, and no single peak was
common to all the species tested.
The robustness of the MALDI–TOF method was
assessed with ﬁve representative strains of the main spe-
cies. Repeatability was evaluated at 100%, as testing colo-
nies from three areas of the same plate and duplicate
tests unambiguously identiﬁed the species, with RS and
RPN values of 0.63–0.98 and 0.39–0.91, respectively. Inter-
estingly, some proﬁles appeared to be strain-speciﬁc as the
ﬁrst match corresponded to the particular strain tested.
Similar to repeatability, reproducibility reached 100%, with
a high conservation of spectrum characteristics between
extracts prepared from two different subcultures, and RS
and RPN scores of 0.62–0.90 and 0.58–0.90, respectively.
The stability of the spectra was tested on serial subcul-
tures for ﬁve species (Table 2). Overall, the spectra exhib-
ited minimal changes upon visual observation. Whatever
the species, the six spectra obtained at each time-point
were correctly identiﬁed up to subculture 9, with scores
of 0.43–0.72 and 0.45–0.80 for RS and RPN, respectively.
This remained true for subculture 11 of F. oxysporum and
F. solani and for subculture 13 of F. verticillioides and F. dime-
rum, but was not conﬁrmed for subculture 11 of F. prolifer-
atum, for which only two-thirds of the spectra were
correctly identiﬁed. In addition, the BIOTYPER ﬁrst hit pro-
vided accurate species identiﬁcation. Results obtained
under different growth conditions are summarized in
Table 3. Compared with malt agar at 27 C, growth on
PDA medium gave 100% correct species identiﬁcation, with
highly similar proﬁles (RS 0.66–0.88, RNP 0.38–0.64), inde-
pendent of species. Similar results were obtained with
SCG medium (RS 0.58–0.83, RNP 0.37–0.62), except for
F. verticillioides. This latter species could not be identiﬁed
when grown at either 37 C on malt medium or 27 C on
SCG medium. Other thermotolerant species, such as
F. dimerum and F. proliferatum, were correctly identiﬁed, but
scores were generally lower.
Mass spectrometry-based identiﬁcation relied on an algo-
rithm developed for routine species identiﬁcation (Fig. 1).
Forty-ﬁve of the 49 strains were correctly identiﬁed as
belonging to one of the ﬁve species represented in our data-
base (Table 1). Among the 45 strains correctly identiﬁed,
four spectra tested identical to one of the MSPs of the data-
base in 39 strains, and three out of four spectra tested iden-
tical to one MSP in six strains.
The four strains with ambiguous results belonged to spe-
cies not included in our database (F. polyphialidicum, F. equis-
eti, F. chlamydosporum and F. sacchari). For ﬁve of six strains
showing discrepancies between morphological and molecular
identiﬁcation, mass spectrometry gave the same result as
DNA sequencing. Finally, strain IHEM7412, identiﬁed mor-
phologically as F. verticillioides and molecularly as F. pseudony-
gamai (99% sequence identity), was identiﬁed as
F. proliferatum by mass spectrometry.
 Comparison to reference database
≥ 3 identical
BioTyper first hits*
with RS>0.3, RPN >0.1
Unknown species
< 3 identical or score values < thresholds
Species identification
Unknown species Fusarium isolate
Mass spectrum determination
Subculture 72 hours on Malt medium at 27°C
. TFA extraction of 2 colonies
Mass spectrometry analysis in duplicate
(4 spectra generated)
 
FIG. 1. Algorithm for identiﬁcation of Fusarium species using a stan-
dardized mass spectrometry proﬁling protocol. *at the species level.
RS, real score; RPN, real p-number (see text for explanation).
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FIG. 2. Matrix-assisted laser desorption ionization–time-of-ﬂight (MALDI–TOF) mass spectra (raw data with no signal treatment) of strains
(see Table 1) used for robustness experiments: (a) Fusarium dimerum IHEM10066; (b) Fusarium oxysporum no. 32; (c) Fusarium proliferatum no. 8;
(d) Fusarium solani IHEM15469, and (e) Fusarium verticillioides IHEM4197.
TABLE 2. Stability testing compar-
ing spectra collected from serial
subcultures with the database
Fusarium strain
Subculture
no. BIOTYPER ﬁrst hit
Mean
RS ± SDa
Mean
RPN ± SDa
F. dimerum IHEM10066 5 F. dimerum IHEM10066 0.91 ± 0.11 0.53 ± 0.06
7 F. dimerum IHEM10066 0.72 ± 0.09 0.80 ± 0.11
13 F. dimerum IHEM10066 0.59 ± 0.11 0.87 ± 0.07
F. oxysporum no. 32 3 F. oxysporum no. 32 0.75 ± 0.03 0.54 ± 0.03
7 F. oxysporum no. 32 0.43 ± 0.06 0.63 ± 0.13
11 F. oxysporum no. 32 0.35 ± 0.08 0.40 ± 0.04
F. proliferatum no. 8 3 F. proliferatum no. 8 0.58 ± 0.02 0.68 ± 0.09
9 F. proliferatum no. 8 0.46 ± 0.11 0.50 ± 0.15
11 Discrepanciesb NA NA
F. verticillioides IHEM4197 5 F. verticillioides IHEM4197 0.46 ± 0.08 0.30 ± 0.08
7 F. verticillioides IHEM4197 0.65 ± 0.05 0.45 ± 0.04
13 F. verticillioides IHEM10153 0.61 ± 0.04 0.41 ± 0.01
F. solani IHEM15469 3 F. solani IHEM15469 0.47 ± 0.07 0.49 ± 0.05
7 F. solani IHEM15469 0.58 ± 0.11 0.48 ± 0.08
11 F. solani IHEM15469 0.74 ± 0.07 0.54 ± 0.06
RS, real score; RPN, real p-number; SD, standard deviation; NA, not applicable.
aMean of scores obtained from BIOTYPER software, calculated for three colonies tested in duplicate.
bTwo spectra were identiﬁed as Fusarium proliferatum no. 8 and the remaining four corresponded to ‘unknown
species’.
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Discussion
In recent years, mass spectrometry has emerged as a power-
ful tool for the identiﬁcation of bacteria [26–28]. Studies
concerning fungal identiﬁcation using this technology have
involved a limited number of strains belonging to different
species of a given genus [22–24], or have focused on non-
human pathogens [21]. No validated databases have been
developed for routine fungal identiﬁcation.
Here, we investigated the value of MALDI–TOF for the
identiﬁcation of Fusarium spp. [3,29]. Molecular approaches
are still time-consuming and targeting the TEF1 gene remains
uncertain for some Fusarium species. Indeed, using two differ-
ent DNA databases, no perfect sequence matches were
found for 12 (19%) of the 62 strains tested in the present
study, although a 100% identity is recommended by the cura-
tors of the Fusarium database for species identiﬁcation [15].
Thus, although our experience shows that 99% sequence
identity fully agrees with morphological identiﬁcation, other
diagnostic tools are needed to facilitate the identiﬁcation of
Fusarium species.
Our undertaking was driven by the goal of providing a val-
idated protocol and a database that can be widely used and
shared. Our database is made up of 13 MSPs from represen-
tatives of the main species involved in human infections. The
database can be integrated into the Biotyper software and
can be easily implemented on other sites.
We ﬁrst standardized pre-analytical steps such as the cul-
ture conditions and protein extraction. We selected a 72-h
incubation period, corresponding to the stationary phase of
growth, thus limiting the variability of the protein content.
Malt medium was chosen as the reference medium because
it promotes fructiﬁcation, which forms the basis for morpho-
logical identiﬁcation. Finally, the temperature was set at
27 C, as growth may be inconsistent at 37 C, notably for
F. oxysporum [30]. As for bacteria [21,23], the choice of cul-
ture medium can affect the mass spectrometry proﬁles of
Fusarium. Indeed, MALDI–TOF analysis produced more dis-
tinguishable peaks on malt agar and PDA media than on SCG
medium. However, these subtle differences did not hamper
identiﬁcation, with the exception of F. verticillioides. The spec-
trum of this latter species was also strongly inﬂuenced by
the incubation temperature, whereas other species were not
signiﬁcantly affected. Thus, the best growth conditions for
MALDI–TOF analysis appear to be malt agar or PDA at
27 C for 72 h. Finally, the spectra were signiﬁcantly affected
only after 11 subcultures; thus, subculturing should not ham-
per the identiﬁcation of isolates using MALDI–TOF proﬁling.
Identiﬁcation of bacteria using mass spectrometry is gen-
erally performed by comparison with a ﬁngerprint database
collection [26,28,31,32]. Such a strategy enables microbiolo-
gists to obtain correct identiﬁcation rates of 75–100%. How-
ever, it has been pointed out that species-speciﬁc markers
are difﬁcult to demonstrate in spectra because overlapping
signal ions increase along with the number of strains regis-
tered in the database. Identiﬁcation using a protein sequence
database has also been proposed, but this elegant method
needs a complete annotated genome sequence and a high-
resolution mass spectrometer to be effectively performed
[33]. In our study, 44 of 48 strains were accurately identiﬁed
in a ﬁrst analysis, carried out blindly, and only one case of
discrepancy was ﬁnally recorded. This shows that by select-
ing a set of representative strains and retaining the most
conserved peaks for each MSP, a database can be reliably
used for Fusarium species identiﬁcation.
TABLE 3. Inﬂuence of culture con-
ditions (medium and temperature)
on mass spectrometry identiﬁcation
Fusarium strain
Culture conditions:
temperature,
medium Biotyper ﬁrst hit Mean RS ± SDa Mean RPN ± SDa
F. dimerum IHEM10066 27 C, PDA F. dimerum IHEM10066 0.69 ± 0.10 0.38 ± 0.13
27 C, SCG F. dimerum IHEM10066 0.83 ± 0.01 0.37 ± 0.04
37 C, Malt F. dimerum IHEM10066 0.67 ± 0.09 0.39 ± 0.13
F. oxysporum no. 32 27 C, PDA F. oxysporum no. 32 0.80 ± 0.04 0.58 ± 0.04
27 C, SCG F. oxysporum no. 32 0.74 ± 0.04 0.54 ± 0.02
37 C, Malt Negative culture – –
F. proliferatum no. 8 27 C, PDA F. proliferatum no. 8 0.66 ± 0.04 0.43 ± 0.03
27 C, SCG F. proliferatum no. 8 0.82 ± 0.04 0.62 ± 0.05
37 C, Malt F. proliferatum no. 8 0.60 ± 0.06 0.36 ± 0.04
F. verticillioides IHEM4197 27 C, PDA F. verticillioides IHEM4197 0.66 ± 0.11 0.45 ± 0.08
27 C, SCG Unknown species – –
37 C, Malt Unknown species – –
F. solani IHEM15469 27 C, PDA F. solani IHEM15469 0.88 ± 0.01 0.64 ± 0.01
27 C, SCG F. solani IHEM15469 0.58 ± 0.06 0.42 ± 0.06
37 C, Malt Negative culture – –
RS, real score; RPN, real p-number; SD, standard deviation; PDA, potato dextrose agar; SCG, Sabouraud
chloramphenicol gentamicin; Malt, malt agar.
aMean of scores obtained from BIOTYPER software, calculated for three colonies tested in duplicate.
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Indeed, mass spectrometry and molecular identiﬁcation
provide results that are consistent, whereas morphological
identiﬁcation appeared to misidentify at least ﬁve strains.
This is not surprising because previous work on Fusarium
[15,34] and other ﬁlamentous fungi [35] has shown similar
discrepancies. Interestingly, all four strains belonging to
species not included in our database, but identiﬁed from
their nucleotide sequences, did not meet the conditions
for correct identiﬁcation (fewer than three spectra with
the same results) and were thus considered as unidentiﬁed
species. Reference strains belonging to these species
should be tested to be included in our database. The only
discrepancies between the molecular and MALDI–TOF
identiﬁcation involved the species F. verticillioides, F. prolifera-
tum or F. peudonygamai, three species known to be closely
related.
One major advantage of MALDI–TOF analysis is that identi-
ﬁcation can be achieved within 1 h, including the extraction
step. Indeed, MALDI–TOF analysis can include dozens of
strains within the same run. By contrast, 1-week-old subcul-
ture on PDA medium is often needed to obtain discriminatory
morphological characteristics, and molecular identiﬁcation
takes a minimum of 2 days.
As these data suggest that, in some instances, not only
species, but also strains can be recognized, the capacity of
MALDI–TOF analysis for infra-species discrimination should
now be investigated. The use of MALDI–TOF analysis to
identify more common fungal pathogens, notably Aspergillus,
would also be of great interest. For example, it has
recently been shown that A. fumigatus, the species most
commonly involved in human aspergillosis, forms a complex
of different species with distinct in vitro susceptibilities to
antifungal drugs [36]. MALDI–TOF has the potential to
become an essential tool for the identiﬁcation of pathogenic
moulds.
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